SS

Sanjay Shamrao Wane

Active Director Director DIN 09262660
DIN 09262660 First appointment Aug 2021
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Shamrao Wane

Data last updated:

Sanjay Shamrao Wane is a Director at Jivak Medical Private Limited (since 2021).

DIN 09262660
Primary Designation Director
First Appointment 11 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jivak Medical Private Limited U86100MH2021PTC359462
Director11 Aug 20212021Active

Directorship timeline

Open interactive timeline →
Jivak Medical Private Limited
Premium access

Shareholding and investment profile for Sanjay Shamrao Wane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Shamrao Wane

Sanjay Shamrao Wane currently holds 1 directorship: Jivak Medical Private Limited (Director, since 11 Aug 2021).

Sanjay Shamrao Wane was first appointed on 11 Aug 2021 as Director at Jivak Medical Private Limited.

The current boards of Sanjay Shamrao Wane's companies include Jayshree Kunal Patil (Jivak Medical Private Limited), Kshama Nitin Shende (Jivak Medical Private Limited), Narendra Damodar Patil (Jivak Medical Private Limited), Pallavi Atul Godghate (Jivak Medical Private Limited), Prafulla Sakhare (Jivak Medical Private Limited), Sanjay Ganpat Ramteke (Jivak Medical Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available